戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 considered as a viable component of a global immunization program.
2 used to monitor the impact of a US rotavirus immunization program.
3 sidents aged 65-70 through a publicly funded immunization program.
4  pneumococcal conjugated vaccine (PCV) child immunization program.
5 10 and 14 weeks of age through the Universal Immunization Program.
6 ccines requires a robust stand-alone routine immunization program.
7 cination prior to the war dropped out of the immunization program.
8 n in the South African Expanded Programme on Immunization program.
9 that may help boost public confidence in the immunization program.
10 lowing introduction of a school-based 4CMenB immunization program.
11 pected, assuming PCV10 was still part of the immunization program.
12 ladesh, HRV was included in Matlab's routine immunization program.
13  that introduced RotaTeq into their national immunization program.
14 orities for introducing them to the National Immunization Program.
15  of the historical strength of the country's immunization program.
16 roduce rotavirus vaccine into their national immunization program.
17  priority health programs like the Universal Immunization Program.
18 nly several countries with a funded male HPV immunization program.
19 ntroduce rotavirus vaccine into its national immunization program.
20 the shift from PCV7 to PCV13 in the national immunization program.
21 se vaccines are introduced in routine infant immunization programs.
22 rts and may reflect the success of childhood immunization programs.
23 njugate vaccine (PCV7) developed in 34 state immunization programs.
24 o begin vaccine safety monitoring in routine immunization programs.
25 gent disease in countries with long-standing immunization programs.
26 red for incorporation into current childhood immunization programs.
27 oing impacts to health care capacity and RSV immunization programs.
28 after the introduction of PCV13 in childhood immunization programs.
29 and teenager MenACWY vaccination in national immunization programs.
30 of intensity of polio vaccine use in routine immunization programs.
31  COVID-19 vaccine and changes in funding for immunization programs.
32  is a major global challenge facing COVID-19 immunization programs.
33 try plans for MACV introduction into routine immunization programs.
34 coccal conjugate vaccine (PCV7) in childhood immunization programs.
35 at the country level reinforces the national immunization programs.
36 PV2 by ceasing use of tOPV in their national immunization programs.
37 ost-effectiveness of which vaccine to use in immunization programs.
38 ement and quality, and strengthening routine immunization programs.
39 pt rotavirus vaccination into their national immunization programs.
40 d the implications for triggered and routine immunization programs.
41 have introduced rotavirus vaccine into their immunization programs.
42 occal conjugate vaccine (PCV7) into national immunization programs.
43 pedes the establishment of effective routine immunization programs.
44 ization services as a strategy to strengthen immunization programs.
45                                              Immunization programs against SARS-CoV-2 with commercial
46                                    Influenza immunization programs aim to reduce the risk and burden
47  implemented 4CMenB into the national infant immunization program, alongside an emergency adolescent
48 cines makes the implementation of a national immunization program an important decision requiring eco
49 an observation with important public health, immunization program and cost implications.
50 ause of low coverage achieved in the routine immunization program and in supplementary immunization a
51 rscore the urgent need to strengthen India's immunization program and investigate the mechanisms driv
52 Gs in the introduction of IPV in the routine immunization program and the lessons learned.
53 ble information for the planning of national immunization programs and future vaccine development.
54 r, cases prevented because of investments in immunization programs and GPEI remain incompletely chara
55  for almost all vaccines contained in global immunization programs and influence immune response for
56 er and into April, establishing school-based immunization programs and other alternative vaccination
57 itical tasks in the strengthening of routine immunization programs and the control of measles and rub
58                      Investments in national immunization programs and the Global Polio Eradication I
59 accine are useful to evaluate the success of immunization programs and to identify susceptible subgro
60  a significant achievement for public health immunization programs and underscores the importance of
61 cies, participating in the implementation of immunization programs, and establishing effective means
62 g gaps in the polio surveillance and routine immunization programs, and provided recommendations for
63 d personnel provide critical support for the immunization programs, and sudden discontinuation of the
64 is is required before further mass varicella immunization programs are set out.
65 ecently, introduction into routine childhood immunization programs associated with extended catch-up
66                                The PCV child immunization program associates with an increased diseas
67              If introduced into the national immunization program at 11 years of age (alongside the e
68 , Bexsero) into its publicly funded national immunization program at a reduced two-dose priming sched
69 ate Hib vaccine within the routine childhood immunization program at ages 6, 10, and 14 weeks beginni
70  reports of integration of MCH services with immunization programs at the service delivery level.
71                          The Swine Influenza Immunization Program began in January 1976 with an outbr
72                              In 2008, an HPV immunization program began with a bivalent vaccine (Cerv
73 evalence against which the impact of the HPV immunization program can be measured in the future.
74 hree particular lessons for other health and immunization programs can be drawn from the experience o
75                                        After immunization, programmed death -1 (PD-1)(high) T(FH) cel
76                   However, the success of an immunization program depends on high rates of acceptance
77 ial of adult vaccines fully, we must enhance immunization programs, dispel misinformation, and invest
78 13) was initially introduced in the national immunization program for children 2-5 years of age, prio
79        The introduction of a publicly funded immunization program for herpes zoster was associated wi
80            The standard schedule of national immunization programs for infants may not be sufficient
81 urrently used to evaluate the impact of mass immunization programs for varicella and therefore extend
82 w rotavirus vaccines are being introduced in immunization programs, global and national estimates of
83                           Before the switch, immunization programs globally had been using approximat
84  of circulating strains as part of a routine immunization program >5 years after its introduction in
85 tings, rotavirus vaccination in the national immunization program has important cost implications, an
86                             China's National Immunization Program has made remarkable achievements bu
87  its establishment in 1978, China's National Immunization Program has made remarkable achievements in
88 virus (HPV) vaccine among girls in the Dutch immunization program has plateaued at around 60%.
89     Implementation of universal-at-birth HBV immunization programs has effectively reduced the occurr
90 al educational immunity through prepregnancy immunization programs has potential for improvement of i
91                              The coverage of immunization programs has reached 60% in 85% of African
92 cently, however, new vigor and strategies in immunization programs have resulted in substantial impro
93 an Republic introduced MACV into its routine immunization program immediately after the mass 1- to 29
94 (PCVs) were introduced into the UK childhood immunization program in 2006 and 2010, respectively, wit
95   Introduction of PCV7 in the Dutch National Immunization Program in 2006 preluded substantial altera
96 te vaccine (PCV13) in the childhood National Immunization Program in 2015-2016 with coverage of 3 dos
97 orating these vaccines into China's National Immunization Program in 2019 could have averted 11 761 d
98 ered to preadolescent girls via the National Immunization Program in a 2-dose schedule since 2014.
99 tavirus vaccine into South Africa's national immunization program in August 2009.
100 baseline against which the impact of the HPV immunization program in Brazil can be measured in future
101 t and cost-effectiveness of the US rotavirus immunization program in children <5 years of age using h
102 V) at >/=14 weeks of age through the routine immunization program in countries currently not using IP
103 ost-benefit analysis of a national rotavirus immunization program in Egypt, from the perspective of t
104  evaluate the effectiveness of a hepatitis B immunization program in eliminating hepatitis B virus (H
105                                          The immunization program in Honduras has sufficient structur
106 ne (Rotavac) was introduced in the universal immunization program in India in 2016.
107 V5) was introduced into the Israeli National Immunization Program in January 2011.
108 lent PCV was introduced to Israel's national immunization program in July 2009 and gradually replaced
109 spectively) were implemented in the national immunization program in July 2009 and November 2010, res
110 irus vaccine (Rotarix(R)) into the UK infant immunization program in July 2013 was associated with la
111  was introduced in the routine public health immunization program in Lusaka, Zambia, in January 2012
112 MD vaccines are included in China's National Immunization Program in order to achieve high coverage r
113 ntegrating TAK-003 into an existing national immunization program in Thailand.
114 rce for monitoring the impact of a rotavirus-immunization program in the United States.
115 savings reflect the success of the rotavirus immunization program in the United States.
116 ced into Alberta, Canada's routine childhood immunization programs in 2002 (7-valent [PCV7]) and 2010
117 paigns followed by introduction into routine immunization programs in 8 of these countries.
118                         Strengthened routine immunization programs in countries with suboptimal cover
119 tributed as seeds, tubers, or fruits, making immunization programs in developing countries cheaper an
120  immunogens could be particularly useful for immunization programs in developing countries, where des
121 ge for the introduction of TCVs into routine immunization programs in endemic countries.
122 inal data on the effectiveness of nirsevimab immunization programs in infants and children aged 24 mo
123 njugate vaccines (PCVs) are used in national immunization programs in many developing countries.
124   There are no public awareness and national immunization programs in most Arab countries.
125  vaccines can be incorporated into childhood immunization programs in the developing world.
126 eir employment would potentially disrupt the immunization programs in their countries and create a se
127 MR countries introduced IPV in their routine immunization program, including all of the countries at
128  introduced MACV into their national routine immunization programs, including 7 with catch-up vaccina
129 ed RCV into their national routine childhood immunization programs increased by 57% from 83 countries
130                                  The routine immunization program information collected included ques
131 itis B vaccine and mass population screening immunization program initiated in 1984 on rates of HBV a
132                                 The National Immunization Program is a vertically integrated programm
133                                              Immunization program managers from 48 states (96%) parti
134       A 2-phase mixed-methods study of state immunization program managers in the United States.
135 al telephone and paper-based survey of state immunization program managers that was conducted from Ja
136 om meetings and personal communications with immunization program managers.
137 wly approved vaccines into routine childhood immunization programs, monitoring their performance in r
138  measles surveillance system at the National Immunization Program (NIP).
139 gate vaccines (PCVs) into pediatric national immunization programs (NIPs) has led to large decreases
140   Drawing from the ill-fated swine influenza immunization program of 1976, this article outlines 7 le
141 ccines have been implemented in the national immunization programs of 79 countries, including 36 low-
142 tivated polio vaccine (IPV) into the routine immunization programs of all countries using oral polio
143                                     National immunization programs offer childhood vaccines through f
144 ted the early impact of the school-based HPV immunization program on cervical dysplasia in women in B
145  dedicated to tasks related to strengthening immunization programs, other than polio eradication.
146   In the context of a robust pediatric PCV13 immunization program, PCV13 vaccination of adults aged 6
147 In New Zealand after multiple changes to the immunization program, PCV13 was re-introduced in 2022, r
148                            RV1 in the Kenyan immunization program provides significant protection aga
149 on of Hib vaccine into the routine childhood immunization program reduced Hib disease incidence among
150 rubella-containing vaccine in their national immunization programs, rubella and CRS continue to occur
151 equire overcoming challenges to the National Immunization Program's future expansion and development.
152 tudies assess population immunity, verify an immunization program's performance and vaccine efficacy,
153 the type 2 component; and strengthen routine immunization programs-set an ambitious series of targets
154                                          HCP immunization programs should consider effects of host im
155                                       4CMenB immunization programs should focus on direct (individual
156                                       Future immunization programs should therefore target these tran
157 lowing introduction of RV1 into the national immunization program, significant declines in hospitaliz
158 rating HBV vaccine in the national childhood immunization program since 2002.
159 e of intervention compatibility and focus on immunization program strength.
160                        In 2000, the National Immunization Program surveyed states, the District of Co
161      In the context of broad-based influenza immunization programs (targeted or universal), severe ou
162                                A hepatitis B immunization program that includes prevention of perinat
163  communications from other aspects of oblast immunization programs, these and other outcome data sugg
164 repares for the full removal of all OPV from immunization programs, this need for lead time and consi
165 ucially important to strengthen the National Immunization Program to attain universal coverage of lif
166  four non-programme vaccines to the National Immunization Program to benefit the Chinese population:
167  also but that it is feasible for a national immunization program to implement fIPV immunization and
168 ntroduce rotavirus vaccine into its national immunization program to reduce the burden of rotavirus d
169                    Countries must strengthen immunization programs to achieve high vaccination covera
170 tOPV highlights the adaptability of national immunization programs to new procedures, and identifies
171 e vaccine (PCV13) into the routine childhood immunization program, to be administered to children at
172 f adding a rotavirus vaccine to the Peruvian immunization program under 3 scenarios for the timing of
173                            Integrated global immunization programs using live-attenuated oral (OPV) a
174                    This has implications for immunization programs, vaccine development, and tubercul
175 literature to assess these four non-National Immunization Program vaccines in terms of their disease
176 duction of rotavirus vaccine to the national immunization program was not found to be cost saving bas
177 ntil recently, waste management for national immunization programs was limited to sharps waste, empty
178 ends, and consider methods for evaluating an immunization program when a vaccine becomes available.
179 eports from countries' ministries of health, immunization programs, WHO, and NITAGs.
180 ction and sequelae is considerable, although immunization programs with broad coverage of the hyper v
181 te vaccine 13 (PCV13), are used in childhood immunization programs worldwide, but direct comparisons
182  (PCVs) are recommended for use in pediatric immunization programs worldwide.
183                               A US rotavirus immunization program would be cost-effective from the pe
184 health care system, although the cost of the immunization program would not be fully offset by the re
185               A routine, universal rotavirus immunization program would prevent 1.08 million cases of

 
Page Top